Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases Tomomi Kogiso; Takaomi Sagawa; Kazuhisa Kodama; Makiko Taniai; Etsuko Hashimoto; Katsutoshi Tokushige;

Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018¿2024) Nahum Méndez-Sánchez; Mariana M. Ramírez-Mejía; Carlos Cortez-Hernández; Elianee M. Tovar-Bojorquez; Raúl Contreras-Omaña; Juan D. Monsiváis-Morales; Jacqueline Cordova-Gallardo; Mauricio Castillo-Barradas; Nubia Guzmán-Rodríguez; María S. González-Huezo; Adrian Sandez-Araiza; Eira Cerda-Reyes; Stefanny Cornejo-Hernández; Beatriz Barranco-Fragoso; Ana D. Cano-Contreras; José M. Remes-Troche; Fatima Higuera-de-la-Tijera; José L. Pérez-Hernández; Norberto Chávez-Tapia; Francisco J. Valentin-Cortez; Iaarah Montalvo-Gordon; Rubén R. Lozano-Salazar; Montserrat Sabanes-Hernández; Itziar Borbolla-Schega; Heriberto Rodríguez-Hernández;

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;